Impact of Vagus Nerve Stimulation for the Treatment of Drug-resistant Epilepsy on Patterns of Use and Cost of Healthcare Services and Pharmacotherapy Among Medicare Enrollees: Findings From Analyses of Healthcare Claims From the Centers of Medicare and Medicaid Services
Open Access
- 25 February 2025
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 47 (5) , 355-362
Abstract
No abstract availableKeywords
Funding Information
- LivaNova Plc
This publication has 16 references indexed in Scilit:
- Patterns of utilization and cost of healthcare services and pharmacotherapy among patients with drug-resistant epilepsy during the two-year period before neurostimulation: A descriptive analysis of the journey to implantation based on analyses of a large United States healthcare claims databaseEpilepsy & Behavior, 2023
- Impact of Vagus Nerve Stimulation for the Treatment of Drug-resistant Epilepsy on Patterns of Use and Cost of Health Care Services and Pharmacotherapy: Comparisons of the 24-Month Periods Before and After ImplantationClinical Therapeutics, 2023
- Neuromodulation - Science and Practice in Epilepsy: Vagus Nerve Stimulation, Thalamic Deep Brain Stimulation, and Responsive NeuroStimulationExpert Review of Neurotherapeutics, 2018
- Descriptive epidemiology of epilepsy in the U.S. population: A different approachEpilepsia, 2015
- Increasing utilization of pediatric epilepsy surgery in the United States between 1997 and 2009Epilepsia, 2015
- Low vitamin D levels are common in patients with epilepsyEpilepsy Research, 2014
- Healthcare utilization and costs in adults with stable and uncontrolled epilepsyEpilepsy & Behavior, 2014
- Multimorbidity in Older AdultsEpidemiologic Reviews, 2013
- Vagus nerve stimulation: Longitudinal follow-up of patients treated for 5 yearsSeizure: European Journal of Epilepsy, 2009
- Health economic consequences related to the diagnosis of fibromyalgia syndromeArthritis & Rheumatism, 2008